Literature DB >> 16304583

The 'ideal' management of retinopathy of prematurity.

G E Quinn1.   

Abstract

AIM: Retinopathy of prematurity continues to be a serious, but largely preventable cause of blindness and its detection and treatment is of increasing importance as survival rates of premature babies increase. This is particularly important in Medium Human Development Countries where the guidelines for detection used in the US or UK may not be appropriate.
METHOD: This report addresses identification of infants at risk for retinopathy of prematurity, detection, and treatment of serious disease, and what to do when treatment fails. RESULTS AND
CONCLUSIONS: Retinopathy of prematurity occurs almost exclusively in small premature babies, but the demographic characteristics of these babies vary depending on where they are born. Detection of serious retinopathy requires carefully timed examinations and the treatment criteria will continue to evolve as new therapies are developed. Timely detection and treatment of serious retinopathy of prematurity minimizes the likelihood of blindness, but it is not always successful.

Entities:  

Mesh:

Year:  2005        PMID: 16304583     DOI: 10.1038/sj.eye.6701960

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  2 in total

1.  Anterior segment ischemia following diode laser photocoagulation for aggressive posterior retinopathy of prematurity.

Authors:  Murat Gunay; Mehmet Ali Sekeroglu; Gokhan Celik; Betul Onal Gunay; Cihan Unlu; Fahri Ovali
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-08-09       Impact factor: 3.117

2.  Retinopathy of Prematurity in the University of Calabar Teaching Hospital, Calabar, Nigeria: An Early Report of a Screening Service.

Authors:  Elizabeth D Nkanga; Chineze Thelma Agweye; Bassey Archibong Etim; Sunny Oteikwu Ochigbo; Martha-Mary Ekong Udoh; Dennis George Nkanga; Jacob Jackson Udoh; Kelly Olalekan Asam-Utiin
Journal:  J West Afr Coll Surg       Date:  2022-07-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.